Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 37
Filtrar
1.
J Clin Periodontol ; 51(8): 1017-1033, 2024 08.
Artigo em Inglês | MEDLINE | ID: mdl-38685818

RESUMO

AIM: To assess the efficacy of heterologous fibrin biopolymer (HFB) in promoting alveolar bone healing after tooth extraction in rats. MATERIALS AND METHODS: The upper right incisors of 48 Wistar rats were extracted. Toothless sockets were filled with HFB (HFBG, n = 24) or blood clot (BCG, n = 24). The tooth extraction sites were subjected to micro-computed tomography (micro-CT), histological, histomorphometric and immunohistochemical (for Runt-related transcription factor 2/Runx2 and tartrate-resistant acid phosphatase/TRAP) analyses on days 0, 7, 14 and 42 after extraction. RESULTS: Socket volume remained similar between days 0 and 14 (69 ± 5.4 mm3), except in the BCG on day 14, when it was 10% lower (p = .043). Although the number of Runx2+ osteoblasts was high and similar in both groups (34 × 102 cells/mm2), the HFBG showed lower inflammatory process and osteoclast activity than BCG at 7 days. On day 14, the number of Runx2+ osteoblasts remained high and similar to the previous period in both groups. However, osteoclast activity increased. This increase was 55% lower in the HFBG than BCG. In the BCG, the presence of an inflammatory process and larger and numerous osteoclasts on day 14 led to resorption of the alveolar bone ridge and newly formed bone. On day 42, numbers of Runx2+ osteoblast and TRAP+ osteoclasts decreased dramatically in both groups. Although the BCG exhibited a more mature cortical bone formation, it exhibited a higher socket reduction (28.3 ± 6.67%) and smaller bone volume (37 ± 5.8 mm3) compared with HFBG (socket reduction of 14.8 ± 7.14% and total bone volume of 46 ± 5.4 mm3). CONCLUSIONS: HFB effectively suppresses osteoclast activity and reduces alveolar bone resorption compared with blood clot, thus preventing three-dimensional bone loss, particularly during the early healing period. HFB emerges as a promising biopharmaceutical material for enhancing healing processes after tooth extraction.


Assuntos
Fibrina , Ratos Wistar , Extração Dentária , Alvéolo Dental , Cicatrização , Microtomografia por Raio-X , Animais , Alvéolo Dental/efeitos dos fármacos , Ratos , Cicatrização/efeitos dos fármacos , Fibrina/uso terapêutico , Masculino , Biopolímeros/uso terapêutico , Biopolímeros/farmacologia , Processo Alveolar/efeitos dos fármacos , Processo Alveolar/patologia , Processo Alveolar/diagnóstico por imagem , Osteoclastos/efeitos dos fármacos
2.
Wounds ; 35(2): 32-35, 2023 02.
Artigo em Inglês | MEDLINE | ID: mdl-36877938

RESUMO

INTRODUCTION: Traditional therapies used to treat chronic wounds are often expensive and, in general, are not adequate to support healing. A promising alternative to conventional dressings is the autologous biopolymer FM, full of cytokines and growth factors that accelerate the healing process of wounds of various etiologies. MATERIALS AND METHODS: The authors report 3 cases in which FM was used to treat chronic oncological wounds that had been conventionally treated for more than 6 months with no sign of healing. RESULTS: Among the 3 reported cases, there was complete healing of 2 wounds. The other lesion did not heal, mainly due to the location (at the base of the skull). However, it significantly reduced its area, extension, and depth. No adverse effects or hypertrophic scar formation were recorded, and the patients reported an absence of pain from the second week of FM application. CONCLUSIONS: The proposed FM dressing approach was effective in healing and speeding up tissue regeneration. It can also be considered one of the most versatile delivery systems to the wound bed, as it is an excellent carrier of growth factors and leukocytes.


Assuntos
Cicatriz Hipertrófica , Cicatrização , Humanos , Bandagens , Biopolímeros/uso terapêutico , Fibrina/uso terapêutico
3.
Molecules ; 28(1)2023 Jan 03.
Artigo em Inglês | MEDLINE | ID: mdl-36615601

RESUMO

Extending the range of use of the heterologous fibrin biopolymer, this pre-clinical study showed a new proportionality of its components directed to the formation of scaffold with a lower density of the resulting mesh to facilitate the infiltration of bone cells, and combined with therapy by laser photobiomodulation, in order to accelerate the repair process and decrease the morphofunctional recovery time. Thus, a transoperative protocol of laser photobiomodulation (L) was evaluated in critical bone defects filled with deproteinized bovine bone particles (P) associated with heterologous fibrin biopolymer (HF). The groups were: BCL (blood clot + laser); HF; HFL; PHF (P+HF); PHFL (P+HF+L). Microtomographically, bone volume (BV) at 14 days, was higher in the PHF and PHFL groups (10.45 ± 3.31 mm3 and 9.94 ± 1.51 mm3), significantly increasing in the BCL, HFL and PHFL groups. Histologically, in all experimental groups, the defects were not reestablished either in the external cortical bone or in the epidural, occurring only in partial bone repair. At 42 days, the bone area (BA) increased in all groups, being significantly higher in the laser-treated groups. The quantification of bone collagen fibers showed that the percentage of collagen fibers in the bone tissue was similar between the groups for each experimental period, but significantly higher at 42 days (35.71 ± 6.89%) compared to 14 days (18.94 ± 6.86%). It can be concluded that the results of the present study denote potential effects of laser radiation capable of inducing functional bone regeneration, through the synergistic combination of biomaterials and the new ratio of heterologous fibrin biopolymer components (1:1:1) was able to make the resulting fibrin mesh less dense and susceptible to cellular permeability. Thus, the best fibrinogen concentration should be evaluated to find the ideal heterologous fibrin scaffold.


Assuntos
Matriz Óssea , Fibrina , Ratos , Animais , Bovinos , Fibrina/uso terapêutico , Ratos Wistar , Regeneração Óssea , Lasers , Bioengenharia , Colágeno , Alicerces Teciduais
4.
Oral Maxillofac Surg ; 27(3): 507-512, 2023 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-35739366

RESUMO

INTRODUCTION: Medication-related osteonecrosis of the jaws (MRONJ) is a complication that develops in patients who use or have used antiresorptive or antiangiogenic medications for the treatment of bone metabolic disease and bone metastases. Clinically, MRONJ is characterized by the appearance of an inflammation in soft tissues and exposure of necrotic bone tissue in mandible or maxilla, for a period of 8 weeks, in patients with no history of head and neck radiotherapy that were being or are being treated with antiresorptive and/or antiangiogenic agents. The fibrin-rich platelets and leukocytes (L-PRF) membrane has been used as an alternative for MRONJ prevention. The aim of this study was to evaluate the use of L-PRF in prevention and treatment of bone necrosis. MATERIAL AND METHODS: The patients included had MRONJ diagnosis confirmed after clinical and radiographic examination and patients whose only therapeutic option was dental extraction. RESULTS: Twenty patients were included in the study and were divided in three groups. Two patients were removed from the study due to previous history of pentoxifylline and tocopherol use. The result of surgical treatment was successful in 57% in group 1 (control/MRONJ prevention), 100% in group 2 (MRONJ prevention), and 80% in group 3 (MRONJ treatment). CONCLUSION: L-PRF is an autologous biomaterial that allows the release of growth factors for a prolonged time, resulting in a better healing, reducing the risk contamination, edema, and postoperative pain, being a great ally in the prevention and treatment of MRONJ because it returns to these patients, mainly quality of life, reducing pain, and recurrent infections commonly seen in the processes of bone necrosis of the jaws.


Assuntos
Osteonecrose da Arcada Osseodentária Associada a Difosfonatos , Conservadores da Densidade Óssea , Fibrina Rica em Plaquetas , Humanos , Ácido Zoledrônico/uso terapêutico , Osteonecrose da Arcada Osseodentária Associada a Difosfonatos/cirurgia , Estudos de Casos e Controles , Plaquetas , Fibrina/uso terapêutico , Qualidade de Vida , Leucócitos , Conservadores da Densidade Óssea/efeitos adversos , Difosfonatos/efeitos adversos
5.
Rev. bras. oftalmol ; 80(2): 146-150, Mar.-Apr. 2021. graf
Artigo em Inglês | LILACS | ID: biblio-1280111

RESUMO

ABSTRACT We propose a novel surgical technique in cases of aggressive recurrent pterygium non-subsidiary of treatment with conjunctival autografts or antimetabolites. Two presented cases were treated with surgical excision and a sutured plasma rich in growth factors membrane (mPRGF) followed by rich in growth factors (PRGF) eye drops treatment. After surgery, dexamethasone, tobramycin and PRGF eye drops were prescribed for 6 weeks. After a 12-month and 3-year post-surgical follow-up respectively, treated eyes with mPRGF did not present relapse, and visual acuity improved in both cases. No ocular complications, pain, eye discomfort nor other symptoms were observed. The combined use of PRGF eye drops and mPRGF seems an effective and safe therapy for recurrent pterygium.


RESUMO Nós propomos uma nova técnica cirúrgica em casos de pterígio agressivo recorrente não subsidiário de tratamento com autoenxertos conjuntivais ou antimetabólitos. Dois casos foram tratados com excisão cirúrgica e um plasma suturado rico em membrana de fatores de crescimento (mPRGF), seguido de tratamento com colírios ricos em fatores de crescimento (PRGF). Após a cirurgia, foram prescritos colírios de dexametasona, tobramicina e PRGF por 6 semanas. Após 12 meses e 3 anos de acompanhamento pós-cirúrgico respectivamente, os olhos tratados com mPRGF não apresentaram recidiva e a acuidade visual melhorou nos dois casos. Não foram observadas complicações oculares, dor, desconforto ocular ou outros sintomas. O uso combinado de colírios de PRGF e mPRGF parece uma terapia eficaz e segura para o pterígio recorrente.


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Idoso , Pterígio/cirurgia , Plasma Rico em Plaquetas , Fibrina Rica em Plaquetas , Soluções Oftálmicas , Recidiva , Reoperação , Procedimentos Cirúrgicos Oftalmológicos/métodos , Curativos Biológicos , Fibrina/uso terapêutico , Ativação Plaquetária , Transplante de Tecidos/métodos , Engenharia Tecidual
6.
J. oral res. (Impresa) ; 6(5): 127-135, May 2017. ilus, tab
Artigo em Inglês | LILACS | ID: biblio-907733

RESUMO

Background: There is currently no gold standard biomaterial for the treatment of periodontal intrabony defects (PIDs). One of the current options is the use of platelet-rich fibrin (PRF). Objective: To determine the clinical effect of PRF in the treatment of PID through a systematic review and meta-analysis. Materials and Methods: A literature search was conducted up to February 2017 in the following biomedical databases: Pubmed, Embase, Scielo, Science Direct, SIGLE, LILACS and in the Cochrane Central Register of Clinical Trials. The selection criteria included: randomized clinical trials published in the last 5 years, reporting clinical effects (probing depth, clinical insertion level or gingival recession), with a follow-up time equal to or greater than 6 months, and sample size larger than or equal to 10 patients reporting the use of PRF as a treatment for PID. The methodological quality of the studies was analyzed using the Cochrane Handbook of Systematic Reviews of Interventions as a reference. Results: The search strategy yielded 20 articles. A reduction in probing depth and an increase in clinical insertion level or a reduction in gingival recession is reported, when using PRF alone or in combination with another biomaterial or substance that stimulates tissue regeneration. Conclusion: The literature suggests that the use of PRF in the treatment of PIDs has a beneficial clinical effect when compared to control treatments.


Assuntos
Humanos , Fibrina/uso terapêutico , Retração Gengival/terapia , Plasma Rico em Plaquetas , Periodontite/terapia , Regeneração Óssea/fisiologia
7.
Artigo em Espanhol | LILACS | ID: biblio-844728

RESUMO

RESUMEN: Este caso clínico de boca dividida a 6 meses tiene como objetivo comparar los resultados obtenidos con una membrana de fibrina rica en plaquetas y leucocitos (L-PRF) y un injerto de tejido conectivo (ITC) en el tratamiento de recesiones gingivales clase1 de Miller en un paciente con biotipo gingival grueso. El resultado muestra que el uso de una membrana de L-PRF provee un parcial cubrimiento de la recesión y un menor malestar subjetivo del paciente cuando se compara con el ITC. Sin embargo, el ITC proporciona un mayor porcentaje de cubrimiento radicular y un mejor resultado estético que la membrana de L-PRF al cabo de 6 meses.


ABSTRACT: The aim of this split-mouth clinical study, covering a 6 month period, is to compare the results obtained from Leucocyte and Platelet Rich Fibrin Membrane (L-PRF) and Connective Tissue Grafting (CTG) in the treatment of class 1 Miller gingival recessions in a patient with thick gingival biotype. The results show that the use of L-PRF membrane provides partial coverage of the recession, as well as lower subjective patient discomfort when compared with CTG. However, CTG provides a higher percentage of root coverage and better aesthetic results than the L-PRF membrane after a period of 6 months.


Assuntos
Humanos , Feminino , Adulto , Plaquetas/fisiologia , Tecido Conjuntivo/transplante , Fibrina/uso terapêutico , Retração Gengival/cirurgia , Membranas Artificiais , Gengivoplastia
8.
ImplantNewsPerio ; 2(2): 271-280, mar.-abr. 2017. tab
Artigo em Português | LILACS, BBO - Odontologia | ID: biblio-847150

RESUMO

Objetivo: realizar uma revisão da literatura acerca do uso do PRF na Implantodontia nos últimos anos, abordando artigos científicos recentes. Material e métodos: foi realizada uma busca na base de dados PubMed, ente os meses de setembro e outubro de 2016, utilizando a associação das palavras-chave na língua inglesa "PRF" e "dental implants". Posteriormente, foi feita uma complementação nas bases de dados Scielo e Google Acadêmico com os mesmos termos na língua portuguesa. Resultados: dez artigos foram selecionados, uma vez que os mesmos respeitavam os critérios de inclusão, incluindo metodologia detalhada, número significativo de pacientes e realização de procedimentos relacionados à instalação de implantes dentais. Todos os estudos avaliados reportaram alguma vantagem no uso do PRF, principalmente em relação ao ganho ósseo. No entanto, todos os estudos apresentaram limitações e apontaram a necessidade de estudos subsequentes com adequada padronização. Conclusão: após a revisão destes estudos, foi possível concluir que o PRF pode ser indicado como adjuvante nos procedimentos de enxertia e na instalação de implantes, e também pode ser utilizado como barreira mecânica em procedimentos em que esta manobra seja necessária para o sucesso final do procedimento de enxertia.


Objective: the aim of the study was to review the literature concerning the use of the PRF in Implantology in the past few years, taking into account the recent articles published in relation to this subject. Material and methods: a search was made on the PubMed (Medline) database, between September and October of 2016, with the terms "PRF" and "dental implants" and also a complementary search in Scielo and Google Academic databases, with the correspondent terms in Portuguese. Results: ten articles were included in the study, once they fulfill the inclusion criteria revealing a detailed methodology, a significant number of patients and with procedures related to the installation of dental implants. All studies evaluated reported some advantage concerning the use of the PRF, mostly in relation to the gain in the bone level. However, all studies also declared limitations of their methodologies and pointed to the necessity in the development of further studies with standard protocols. Conclusion: after revision of the mentioned articles, it was possible to conclude that the PRF can be used as an adjuvant in the grafting procedures and in the dental implant installation, also, can be used as a mechanical barrier in procedures that this kind of barrier is necessary to ensure success in the grafting procedure.


Assuntos
Humanos , Materiais Biocompatíveis , Implantes Dentários , Fibrina/uso terapêutico , Plasma Rico em Plaquetas
9.
Braz Oral Res ; 31: e15, 2017 01 26.
Artigo em Inglês | MEDLINE | ID: mdl-28146219

RESUMO

Anorganic bovine bone mineral (ABBM) is extensively used in the treatment of intra-bony defects. Platelet-rich fibrin (PRF) is a new-generation platelet concentrate with a simplified technique. Although certain studies have reported the use of PRF in the treatment of intra-bony defects, to date, none of them have evaluated its additive effects with ABBM. Therefore, a randomised, split-mouth clinical trial was conducted to compare healing of intra-bony defects treated with an ABBM-PRF combination with healing of those treated with ABBM alone. By using a split-mouth design, 15 paired intra-bony defects were randomly treated with either ABBM alone (control group) or ABBM-PRF combination (test group). Following clinical parameters and radiographical measurements were recorded at baseline and 6 months after treatment: plaque index (PI), gingival index (GI), probing depth (PD), gingival recession (GR), clinical attachment level (CAL), vertical bone loss, depth of defect and defect angle. Preoperative clinical and radiographical measurements were similar for the test and control groups. Statistically significant reductions in GI, PD, CAL, vertical bone loss, depth of intra-bony defect and widening of defect angle were detected after treatment in both groups. With respect to inter-group analysis, gain in CAL was significantly greater in the test group than in the control group, whereas no inter-group differences were observed in any other parameter. The results of this study indicate that both therapies are effective in the treatment of intra-bony defects.


Assuntos
Perda do Osso Alveolar/terapia , Plaquetas , Regeneração Óssea/efeitos dos fármacos , Substitutos Ósseos/uso terapêutico , Fibrina/uso terapêutico , Cicatrização/efeitos dos fármacos , Adulto , Perda do Osso Alveolar/diagnóstico por imagem , Animais , Bovinos , Terapia Combinada , Índice de Placa Dentária , Feminino , Retração Gengival , Humanos , Masculino , Pessoa de Meia-Idade , Índice Periodontal , Reprodutibilidade dos Testes , Estatísticas não Paramétricas , Fatores de Tempo , Resultado do Tratamento
10.
ImplantNewsPerio ; 2(1): 48-55, jan.-fev. 2017. ilus
Artigo em Português | LILACS, BBO - Odontologia | ID: biblio-847076

RESUMO

Uma paciente do sexo feminino, com 72 anos de idade e exposição óssea intraoral, portadora de osteoporose, fazia uso de bifosfonatos há mais de cinco anos. Na região posterior mandibular direita havia osso exposto, hiperemia dos tecidos moles e exsudato purulento. A região mandibular anterior mostrava drenagem de secreção purulenta. Como havia necessidade de cirurgia de fêmur por recomendação médica, a paciente foi submetida à medicação específica (amoxicilina 500 mg, metronidazol 400 mg) e irrigação local com clorexidina 0,12%. Seis meses depois, e mediante os exames de TCFC e CTx sérico, foi realizada a terapia com fibrina leucoplaquetária autóloga. Estas biomembranas foram colocadas nas áreas de osso necrótico. Depois de 15 dias, observou-se uma grande exposição da área operada. Porém, clinicamente, já se notava neovascularização. Após 30 dias, havia grande epitelização da área que se encontrava exposta anteriormente. O caso foi controlado por mais 30 dias, totalizando 60 dias, podendo ser observada uma grande cobertura de tecido mole bem vascularizada e queratinizada na região. As terapias propostas para tratamento não apresentam eficácia suficiente para serem consideradas como protocolos. Dentro dos limites deste relato, a utilização da fibrina leucoplaquetária autóloga apresentou-se favorável como alternativa após dez meses e sem recidivas, abrindo perspectivas para tratar as necroses induzidas por estes medicamentos.


A 72 years-old female patient presented with intraoral bone exposure, osteoporosis, and bisphosphonate use (> 5 years). Also, at the posterior mandible, there was soft tissue hyperemia and pus. On the other hand, the anterior mandible presented with purulent drainage. Due to the need of a hip replacement by medical recommendation, the patient was submitted to specific pharmacological regimen (Amoxicillin 500 mg, Metronidazole 400 mg), and 0.12% chlorhexidine rinses. Six months later, and after CBCT and seric CTx exams, the autologous leukocyte platelet-rich fibrin therapy was applied. These biomembranes covered areas of necrotic bone. After 15 days, there was great exposition at the surgical area. However, neovascularization was clinically observed followed 30 days later by epithelization of previously exposed areas. The case was controlled for more 30 days, where well-vascularized and keratinized soft tissue coverage was identified. The proposed therapy does not provide efficacy to be considered as protocols. However, within the limits of this presentation, the autologous leukocyte platelet-rich fibrin seems to be favorable as an alternative and after 10 months no complications were observed. This opens new perspectives to treat bisphosphonate induced bone necrosis.


Assuntos
Humanos , Feminino , Idoso , Materiais Biocompatíveis , Osteonecrose da Arcada Osseodentária Associada a Difosfonatos , Difosfonatos , Fibrina/uso terapêutico , Osteonecrose/tratamento farmacológico , Osteonecrose/terapia
11.
ImplantNewsPerio ; 2(1): 57-63, jan.-fev. 2017. tab
Artigo em Português | LILACS, BBO - Odontologia | ID: biblio-847077

RESUMO

Objetivo: realizar uma revisão da literatura em bases de dados eletrônicos sobre as evidências da eficácia da fibrina rica em plaquetas. Material e métodos: a partir dos bancos de dados Medline, PubMed e ClinicalKey, de março a junho de 2016, foi realizada um revisão integrativa de trabalhos sistemáticos e longitudinais. Dois revisores independentes avaliaram os critérios de inclusão e exclusão dos artigos, sendo incluídos artigos publicados de 2011 a maio de 2016. Resultados: a busca eletrônica resultou em um total de 16 referências. Conclusão: os estudos, em sua maioria, relataram aceleração do processo de cicatrização do tecido mole e diminuição da severidade das sequelas pós-operatórias imediatas em Odontologia.


Objective: to review the literature in electronic databases about the evidence of platelet rich fibrin efficiency. Material and methods: Medline, PubMed and ClinicalKey databases were searched from March to June 2016 using a combination of specific search terms. Two independent reviewers assessed the criteria for inclusion and exclusion of articles. with selected articles from 2011 to May 2016. Results: the electronic search resulted in a total of 16 references. Conclusion: most of the studies reported an acceleration of soft tissue healing process and severity decrease of the immediate postoperative sequelae in Dentistry.


Assuntos
Materiais Biocompatíveis , Plaquetas , Regeneração Óssea , Fibrina/uso terapêutico , Plasma Rico em Plaquetas
12.
Phlebology ; 32(7): 488-495, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27703067

RESUMO

Objectives Compare the efficacy and safety of fibrin gel to 8% papain gel for wound dressing of venous ulcers. Method Patients with chronic venous ulcers were randomly assigned to one in three groups: Group 1-fibrin gel; Group 2-8% papain gel; Group 3-carbopol gel (control). Patients were seen every 15 days during 2 months, verifying reduction of the ulcer area, local infection, exudation, and epithelization. All serious or nonserious adverse events were recorded. Results Fifty-five patients (total of 63 ulcers) were randomly distributed in three groups (G1 = 21; G2 = 19; G3 = 23). No patient was excluded or discontinued treatment throughout the study. The areas of the ulcers were similarly reduced in all groups (14.3%, 21.1%, and 30.4% in groups 1, 2, and 3, respectively), and all had significant reduction in exudation and contamination. Conclusion The data demonstrate that neither fibrin gel nor papain gel were able to improve the process of ulcer-healing, as compared to control.


Assuntos
Fibrina/uso terapêutico , Géis , Papaína/uso terapêutico , Úlcera Varicosa/terapia , Adulto , Idoso , Idoso de 80 Anos ou mais , Bandagens , Doença Crônica , Método Duplo-Cego , Elasticidade , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Resultado do Tratamento , Cicatrização
13.
Braz. oral res. (Online) ; 31: e15, 2017. tab, graf
Artigo em Inglês | LILACS | ID: biblio-839515

RESUMO

Abstract Anorganic bovine bone mineral (ABBM) is extensively used in the treatment of intra-bony defects. Platelet-rich fibrin (PRF) is a new-generation platelet concentrate with a simplified technique. Although certain studies have reported the use of PRF in the treatment of intra-bony defects, to date, none of them have evaluated its additive effects with ABBM. Therefore, a randomised, split-mouth clinical trial was conducted to compare healing of intra-bony defects treated with an ABBM-PRF combination with healing of those treated with ABBM alone. By using a split-mouth design, 15 paired intra-bony defects were randomly treated with either ABBM alone (control group) or ABBM-PRF combination (test group). Following clinical parameters and radiographical measurements were recorded at baseline and 6 months after treatment: plaque index (PI), gingival index (GI), probing depth (PD), gingival recession (GR), clinical attachment level (CAL), vertical bone loss, depth of defect and defect angle. Preoperative clinical and radiographical measurements were similar for the test and control groups. Statistically significant reductions in GI, PD, CAL, vertical bone loss, depth of intra-bony defect and widening of defect angle were detected after treatment in both groups. With respect to inter-group analysis, gain in CAL was significantly greater in the test group than in the control group, whereas no inter-group differences were observed in any other parameter. The results of this study indicate that both therapies are effective in the treatment of intra-bony defects.


Assuntos
Humanos , Animais , Masculino , Feminino , Adulto , Bovinos , Cicatrização/efeitos dos fármacos , Plaquetas , Regeneração Óssea/efeitos dos fármacos , Fibrina/uso terapêutico , Perda do Osso Alveolar/terapia , Substitutos Ósseos/uso terapêutico , Fatores de Tempo , Índice Periodontal , Índice de Placa Dentária , Reprodutibilidade dos Testes , Perda do Osso Alveolar/diagnóstico por imagem , Resultado do Tratamento , Terapia Combinada , Estatísticas não Paramétricas , Retração Gengival
14.
Full dent. sci ; 8(30): 41-49, 2017. ilus
Artigo em Português | BBO - Odontologia | ID: biblio-909830

RESUMO

Com o avanço da tomografia computadorizada, a reabilitação oral com implantes osseointegráveis em pacientes edêntulos totais tornou-se mais segura e rápida, tendo como ferramenta softwares capazes de converter imagens em protótipos e guias cirúrgicos tridimensionais previamente planejados, tornando o momento cirúrgico menos traumático. Com a otimização das técnicas cirúrgicas, protéticas e de imagem, criou-se a cirurgia guiada, caracterizada por nova filosofia envolvendo a reabilitação por implantes. Mesmo com o avanço tecnológico, a perda da estabilidade primária pode ocorrer, levando, em muitas situações, ao comprometimento do caso. Este artigo tem como objetivo principal mostrar através de um relato de caso todas as etapas que passam pelo planejamento, técnica cirúrgica e pós-operatório da cirurgia guiada, demonstrando o potencial da fibrina leucoplaquetária autóloga como auxiliar no reparo para recuperação de implantes com perda da estabilidade primária (AU).


Due to the evolution of computer tomography advance, oral rehabilitation using bone integrated implants in totally edentulous patients became safer and faster, using software capable of converting images into tridimensional prototypes and surgery guides previously planned, making the surgery less traumatic. The optimization of surgerical, prosthetics and image techniques resulted on guided surgery characterized by a new philosophic view over implant rehabilitation. Even with advanced technology the loss of primary stability may occur compromising the success of the treatment. This article aims at demonstrating through a case report every step related to guided surgeries including planning, surgical techniques, and postoperative, focusing on the autologous fibrin buffy as auxiliary in the optimized fix during recoveries from implants without primary stability (AU).


Assuntos
Humanos , Pessoa de Meia-Idade , Relatos de Casos , Implantes Dentários , Fibrina/uso terapêutico , Osseointegração , Cirurgia Assistida por Computador/métodos , Tomografia Computadorizada por Raios X/instrumentação , Brasil
15.
ImplantNewsPerio ; 1(7): 1293-1299, out.-nov. 2016. ilus
Artigo em Português | LILACS, BBO - Odontologia | ID: biblio-847933

RESUMO

Esse trabalho teve por objetivo apresentar a fibrina leucoplaquetária autóloga como alternativa de tratamento para perfuração significativa da mucosa sinusal, durante cirurgia de elevação do assoalho do seio maxilar. O presente caso clínico relatou a obtenção da fibrina leucoplaquetária autóloga, o procedimento cirúrgico para levantamento de assoalho do seio maxilar pela técnica da janela lateral, a reparação da perfuração crítica da mucosa sinusal utilizando membranas de fibrina leucoplaquetária autóloga e os resultados alcançados. No caso exposto, a fibrina


This work aims to present the autologous leukocyte and platelet-rich fibrin as a treatment alternative for the sinus mucosa perforation during sinus floor elevation surgery. This case reports on how to obtain the autologous concentrate, the surgical procedure with the lateral window technique, the critical-size perforation repair with leukocyte platelet-rich membranes, as well as the results. In this situation, the autologous leukocyte platelet-rich fibrin demonstrated to be an efficient method to treat a large sinus mucosa perforation.


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Materiais Biocompatíveis , Transplante Ósseo , Fibrina/uso terapêutico , Osteotomia , Levantamento do Assoalho do Seio Maxilar , Cirurgia Bucal/métodos
16.
Pesqui. vet. bras ; 36(6): 461-467, jun. 2016. tab, ilus
Artigo em Português | VETINDEX | ID: vti-339553

RESUMO

O plasma rico em plaquetas (PRP) é conhecido por apresentar propriedades anabólicas, anti-inflamatórias e capacidade de gelificação. Atualmente o PRP é considerado eficaz na reparação da cartilagem, sendo sua capacidade de formação de gel indicada para o preenchimento de defeitos condrais. O objetivo desse estudo foi analisar o uso do PRP ativado, no formato de arcabouço, como suporte para o implante de células tronco mesenquimais (CTM), no preenchimento e tratamento de lesões condrais induzidas em equinos. Doze equinos foram submetidos a uma cirurgia artroscópica no tempo zero do experimento (T0), onde foi induzida uma lesão condral de 15 mm de diâmetro na tróclea medial femoral dos membros pélvicos direito. As 12 articulações foram divididas em dois grupos distintos com seis articulações cada (GA e GB). As articulações do GA foram submetidas ao tratamento com o implante de CTM em gel de PRP. As articulações de GB foram o grupo controle do experimento. As CTMs foram extraídas do tecido adiposo e o PRP em gel foi obtido por protocolo de dupla centrifugação seguido da adição de trombina liofilizada. Após cinco meses (T150) foi realizada nova artroscopia para avaliação macroscópica do local, coleta de amostras do tecido de reparação para análises de microscopia eletrônica, sendo realizadas imagens ressonância magnética e tomografia computadorizada no local do implante no GA. Observamos que o gel de PRP associado às CTM demonstrou ser adequado no tratamento de defeitos condrais experimentais dos equinos. GA evidenciou um melhor aspecto macroscópico e microscópico do tecido de reparação, sendo que GB mostrou maior desorganização das fibras colágenas. Nas imagens de ressonância magnética e tomografia computadorizada apenas foi relevante o local da lesão condral. O arcabouço de gel de PRP demonstrou ser apropriado no suporte do tratamento com as CTMs, sendo de fácil aplicação e efetivo, demonstrando resultados promissores na reparação de lesões condrais induzidas.(AU)


The platelet-rich plasma (PRP) is characterized by its anabolic, anti-inflammatory and gelling capability. Nowadays, the PRP is considered effective in the repair of cartilage defects, and its gelling capability is proper to filling chondral defects. So, the aim of this study was to investigate the use of activated PRP as a fibrin gel scaffold, such as support for the use with mesenchymal stem cells (MSC), on the treatment of experimentally chondral articular defects. Twelve horses were subjected to an arthroscopic surgery at time zero of the experiment (T0). A chondral defect of 15 mm diameter was created on the medial femoral trochlea and these 12 joints were divided into two groups each with six joints in each group (GA and GB). The joints of the GA were treated with implantation of MSC and PRP-gel. GB joints were the control group. MSCs were cultivated from adipose tissue and PRP-gel was obtained by double centrifugation protocol followed by addition of lyophilized thrombin. After five months (T150) was performed new arthroscopy for macroscopic evaluation of the defect local, collect samples of tissue repair for electron microscopy assessment and also was implemented a magnetic resonance images and computed tomography on GA. It was observed that the PRP-gel associated with CTMs showed a suitable treatment of experimental chondral defects in horses. GA showed a better macroscopic and microscopic appearance of the tissue repair. GB showed smaller number of chondrocytes and increased collagen fibers disorganization. At the magnetic resonance and computed tomography imaging only the local of chondral defect was viewed. The PRP-gel scaffold was satisfactory to use and support MSCs implantation. It showed an easy handling and it was effective, showing a promising results in the repair of induced chondral defects.(AU)


Assuntos
Animais , Plasma Rico em Plaquetas , Células-Tronco Adultas , Cavalos/lesões , Doenças das Cartilagens/terapia , Doenças das Cartilagens/veterinária , Fibrina/uso terapêutico , Terapia Baseada em Transplante de Células e Tecidos/veterinária , Artroscopia/veterinária
17.
Pesqui. vet. bras ; Pesqui. vet. bras;36(6): 461-467, jun. 2016. tab, ilus
Artigo em Português | LILACS, VETINDEX | ID: lil-792614

RESUMO

O plasma rico em plaquetas (PRP) é conhecido por apresentar propriedades anabólicas, anti-inflamatórias e capacidade de gelificação. Atualmente o PRP é considerado eficaz na reparação da cartilagem, sendo sua capacidade de formação de gel indicada para o preenchimento de defeitos condrais. O objetivo desse estudo foi analisar o uso do PRP ativado, no formato de arcabouço, como suporte para o implante de células tronco mesenquimais (CTM), no preenchimento e tratamento de lesões condrais induzidas em equinos. Doze equinos foram submetidos a uma cirurgia artroscópica no tempo zero do experimento (T0), onde foi induzida uma lesão condral de 15 mm de diâmetro na tróclea medial femoral dos membros pélvicos direito. As 12 articulações foram divididas em dois grupos distintos com seis articulações cada (GA e GB). As articulações do GA foram submetidas ao tratamento com o implante de CTM em gel de PRP. As articulações de GB foram o grupo controle do experimento. As CTMs foram extraídas do tecido adiposo e o PRP em gel foi obtido por protocolo de dupla centrifugação seguido da adição de trombina liofilizada. Após cinco meses (T150) foi realizada nova artroscopia para avaliação macroscópica do local, coleta de amostras do tecido de reparação para análises de microscopia eletrônica, sendo realizadas imagens ressonância magnética e tomografia computadorizada no local do implante no GA. Observamos que o gel de PRP associado às CTM demonstrou ser adequado no tratamento de defeitos condrais experimentais dos equinos. GA evidenciou um melhor aspecto macroscópico e microscópico do tecido de reparação, sendo que GB mostrou maior desorganização das fibras colágenas. Nas imagens de ressonância magnética e tomografia computadorizada apenas foi relevante o local da lesão condral. O arcabouço de gel de PRP demonstrou ser apropriado no suporte do tratamento com as CTMs, sendo de fácil aplicação e efetivo, demonstrando resultados promissores na reparação de lesões condrais induzidas.(AU)


The platelet-rich plasma (PRP) is characterized by its anabolic, anti-inflammatory and gelling capability. Nowadays, the PRP is considered effective in the repair of cartilage defects, and its gelling capability is proper to filling chondral defects. So, the aim of this study was to investigate the use of activated PRP as a fibrin gel scaffold, such as support for the use with mesenchymal stem cells (MSC), on the treatment of experimentally chondral articular defects. Twelve horses were subjected to an arthroscopic surgery at time zero of the experiment (T0). A chondral defect of 15 mm diameter was created on the medial femoral trochlea and these 12 joints were divided into two groups each with six joints in each group (GA and GB). The joints of the GA were treated with implantation of MSC and PRP-gel. GB joints were the control group. MSCs were cultivated from adipose tissue and PRP-gel was obtained by double centrifugation protocol followed by addition of lyophilized thrombin. After five months (T150) was performed new arthroscopy for macroscopic evaluation of the defect local, collect samples of tissue repair for electron microscopy assessment and also was implemented a magnetic resonance images and computed tomography on GA. It was observed that the PRP-gel associated with CTMs showed a suitable treatment of experimental chondral defects in horses. GA showed a better macroscopic and microscopic appearance of the tissue repair. GB showed smaller number of chondrocytes and increased collagen fibers disorganization. At the magnetic resonance and computed tomography imaging only the local of chondral defect was viewed. The PRP-gel scaffold was satisfactory to use and support MSCs implantation. It showed an easy handling and it was effective, showing a promising results in the repair of induced chondral defects.(AU)


Assuntos
Animais , Células-Tronco Adultas , Doenças das Cartilagens/terapia , Doenças das Cartilagens/veterinária , Fibrina/uso terapêutico , Cavalos/lesões , Plasma Rico em Plaquetas , Artroscopia/veterinária , Terapia Baseada em Transplante de Células e Tecidos/veterinária
18.
ImplantNewsPerio ; 1(3): 558-562, abr.-mai. 2016.
Artigo em Português | LILACS, BBO - Odontologia | ID: biblio-847620

RESUMO

As evidências na literatura dos efeitos benéficos dos concentrados de plaqueta, obtidos do sangue autólogo em procedimentos cirúrgicos periodontais, têm aumentado muito nos últimos anos. O uso da fibrina rica em plaquetas ainda se encontra na fase inicial, porém, o potencial clínico de suas aplicações é muito promissor. O objetivo desta revisão foi conceituar o uso da fibrina rica em plaquetas como um procedimento que visa à regeneração das estruturas periodontais perdidas. Pôde-se concluir que a fibrina rica em plaquetas tem grande potencial de aplicação nas cirurgias periodontais e peri-implantares, demonstrando ser eficaz no tratamento de defeitos infraósseos de três paredes e de furca II mandibulares, sendo um procedimento de baixa complexidade e morbidade, de fácil aplicação clínica e com baixo custo.


The evidence in the literature of the beneficial effects of platelet concentrates obtained from autologous blood in periodontal surgical procedures has increased significantly in recent years. The use of platelet-rich fibrin is still in its early days; however, their clinical application is very promising. The objective of this review was to conceptualize the use of platelet-rich fibrin as a procedure which aims to the regeneration of lost periodontal structures. It could be concluded that platelet-rich fibrin have great potential for application in periodontal and peri-implant surgeries and have shown to be effective in treating intra-bony 3 walls and mandibular furcation II defects, being a low complexity and morbidity procedure, easy for clinical applicability and of a low cost.


Assuntos
Humanos , Plaquetas , Regeneração Tecidual Guiada Periodontal , Periodontia , Plasma Rico em Plaquetas , Fibrina/uso terapêutico
19.
J Periodontol ; 87(3): 281-90, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26561997

RESUMO

BACKGROUND: The aim of this systematic review is to evaluate the effects of platelet-rich fibrin (PRF) membranes on the outcomes of clinical treatments in patients with gingival recession. METHODS: Articles that were published before June 2015 were searched electronically in four databases without any date or language restrictions and searched manually in regular journals and unpublished studies. The eligibility criteria comprised randomized controlled trials (RCTs) and prospective controlled trials with follow-up periods of ≥ 6 months that compared the performance of PRF to other biomaterials in the treatment of Miller Class I or II gingival recessions. For the meta-analysis, the inverse variance method was used in fixed- or random-effect models, which were chosen according to heterogeneity. The estimates of the intervention effects were expressed as the mean differences in percentages or millimeters. RESULTS: Six RCTs and one prospective clinical trial are included in this review. Root coverage (RC) and clinical attachment level (CAL) did not differ significantly between the analyzed subgroups (P = 0.57 and P = 0.50, respectively). The keratinized mucosa width (KMW) gain was significantly greater (P = 0.04) in the subgroup that was treated with connective tissue grafts. CONCLUSION: The results of the meta-analysis suggest that the use of PRF membranes did not improve the RC, KMW, or CAL of Miller Class I and II gingival recessions compared with the other treatment modalities.


Assuntos
Retração Gengival , Plaquetas , Tecido Conjuntivo , Fibrina/uso terapêutico , Gengiva , Retração Gengival/tratamento farmacológico , Humanos , Estudos Prospectivos , Retalhos Cirúrgicos , Resultado do Tratamento
20.
Rev. bras. cir. plást ; 31(4): 561-564, 2016. ilus
Artigo em Inglês, Português | LILACS | ID: biblio-827463

RESUMO

Seroma formation remains a common complication of abdominoplasty. The use of drain, flap fixation points, and fibrin glue has been described to reduce the incidence of seroma formation. The authors present herein an easyto- reproduce technique to decrease the risk of bleeding and eliminate the devitalized tissue caused by the detachment. The proposed strategy consists of washing and debridement, which was conducted with mechanical friction using moist flap and abdominal wall dressings.


A formação de seroma após uma abdominoplastia continua sendo uma complicação frequente. O uso de dreno, os pontos de fixação do retalho e o uso da cola de fibrina foram descritos com a finalidade de diminuir a sua incidência. Os autores apresentam uma técnica de fácil reprodução para reduzir o risco de sangramento, bem como para eliminar o tecido desvitalizado decorrente do descolamento. A tática proposta constitui-se de lavagem e desbridamento por meio da fricção mecânica com compressas umedecidas do retalho e da parede abdominal.


Assuntos
Humanos , Complicações Pós-Operatórias , Retalhos Cirúrgicos , Fibrina , Parede Abdominal , Desbridamento , Seroma , Difusão de Inovações , Abdome , Abdominoplastia , Complicações Pós-Operatórias/cirurgia , Complicações Pós-Operatórias/terapia , Retalhos Cirúrgicos/cirurgia , Fibrina/análise , Fibrina/uso terapêutico , Parede Abdominal/cirurgia , Desbridamento/métodos , Seroma/cirurgia , Seroma/terapia , Abdominoplastia/efeitos adversos , Abdominoplastia/métodos , Abdome/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA